Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2017

  • ID: 4401992
  • Report
  • 311 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • 410 Medical Inc
  • BioCardia Inc
  • Eli Lilly and Co
  • Imagnus Biomedical Inc.
  • Medtronic plc
  • SC Pharmaceuticals Inc
  • MORE
Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2017" provides an overview of Drug Delivery Infusion Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Drug Delivery Infusion Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Drug Delivery Infusion Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Drug Delivery Infusion Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Drug Delivery Infusion Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 410 Medical Inc
  • BioCardia Inc
  • Eli Lilly and Co
  • Imagnus Biomedical Inc.
  • Medtronic plc
  • SC Pharmaceuticals Inc
  • MORE
1 Table of Contents
2 Introduction
2.1 Drug Delivery Infusion Systems Overview
3 Products under Development
3.1 Drug Delivery Infusion Systems - Pipeline Products by Stage of Development
3.2 Drug Delivery Infusion Systems - Pipeline Products by Segment
3.3 Drug Delivery Infusion Systems - Pipeline Products by Territory
3.4 Drug Delivery Infusion Systems - Pipeline Products by Regulatory Path
3.5 Drug Delivery Infusion Systems - Pipeline Products by Estimated Approval Date
3.6 Drug Delivery Infusion Systems - Ongoing Clinical Trials
4 Drug Delivery Infusion Systems - Pipeline Products under Development by Companies
4.1 Drug Delivery Infusion Systems Companies - Pipeline Products by Stage of Development
4.2 Drug Delivery Infusion Systems - Pipeline Products by Stage of Development
5 Drug Delivery Infusion Systems Companies and Product Overview
5.1 410 Medical Inc Company Overview
5.2 Acuros GmbH Company Overview
5.3 Adept Medical Ltd Company Overview
5.4 AktiVax Inc. Company Overview
5.5 Alnylam Pharmaceuticals Inc Company Overview
5.6 AngioDynamics Inc Company Overview
5.7 Automedics Medical Systems Inc (Inactive) Company Overview
5.8 Baxter International Inc Company Overview
5.9 Becton Dickinson and Co Company Overview
5.10 BioCardia Inc Company Overview
5.11 BioQ Pharma Inc Company Overview
5.12 ClearLine MD Company Overview
5.13 Debiotech SA Company Overview
5.14 Edwards Lifesciences Corp Company Overview
5.15 Eksigent Technologies LLC Company Overview
5.16 Elcam Medical Company Overview
5.17 Eli Lilly and Co Company Overview
5.18 EryDel SPA Company Overview
5.19 Flowonix Medical Inc Company Overview
5.20 FluidSynchrony, LLC Company Overview
5.21 Fluonic, Inc. Company Overview
5.22 Fresenius Kidney Care Company Overview
5.23 Hospira Inc Company Overview
5.24 Imagnus Biomedical Inc. Company Overview
5.25 Innovfusion Pte. Ltd. Company Overview
5.26 Intarcia Therapeutics Inc Company Overview
5.27 IRadimed Corp Company Overview
5.28 Ivenix Inc Company Overview
5.29 LifeMedix, LLC Company Overview
5.30 Lynntech Inc Company Overview
5.31 Massachusetts Institute of Technology Company Overview
5.32 Medallion Therapeutics, Inc. Company Overview
5.33 Medical Device Creations Ltd. Company Overview
5.34 MedPrime Technologies Pvt. Ltd. Company Overview
5.35 Medtronic plc Company Overview
5.36 Nano Precision Medical Inc Company Overview
5.37 NexGen Medical Systems Inc Company Overview
5.38 Nipro Corp Company Overview
5.39 Owen Mumford Ltd Company Overview
5.40 Pavmed Inc Company Overview
5.41 PRO-IV Medical Ltd Company Overview
5.42 Ratio Inc Company Overview
5.43 Rice University Company Overview
5.44 SC Pharmaceuticals Inc Company Overview
5.45 SteadyMed Therapeutics Inc Company Overview
5.46 StnDrd Infusion Corporation Company Overview
5.47 Surefire Medical Inc Company Overview
5.48 Tandem Diabetes Care Inc Company Overview
5.49 Terumo Corp Company Overview
5.50 ToucheMedical Ltd. Company Overview
5.51 Turnpoint Medical Devices Inc Company Overview
5.52 Unilife Corporation Company Overview
5.53 University of Minnesota Company Overview
5.54 University of Southern California Company Overview
5.55 vTitan Corporation Pvt Ltd Company Overview
6 Drug Delivery Infusion Systems- Recent Developments
6.1 Sep 15, 2017: New Intarcia Study Evaluates Optimal Way to Switch from Daily Liraglutide Injections to ITCA 650 in Patients with Type 2 Diabetes
6.2 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY
6.3 Sep 08, 2017: Fresenius Kabi marks 20-year anniversary of Friedberg production site - Logistics center expansion planned
6.4 Sep 07, 2017: Lilly Takes Steps To Streamline Business, Invest In New Medicines And Drive Growth
6.5 Sep 05, 2017: RMS Receives FDA Clearance for 510(k)
6.6 Aug 31, 2017: Admedus Financial Results For The Year Ended 30 June 2017
6.7 Aug 30, 2017: Smiths Medical Receives FDA 510(k) Clearance on Wireless Ambulatory Infusion Pump
6.8 Aug 30, 2017: Ablative Solutions Announces Presentation at the Baird Global Healthcare Conference
6.9 Aug 24, 2017: Tandem Diabetes Care Announces Issuance of Patent Related to Remote Bolus Feature for Medical Infusion Pumps
6.10 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.11 Aug 15, 2017: Changes in Novo Nordisk Executive Management
6.12 Aug 14, 2017: MicroPort Lifesciences Hosts GnRH Pump Treatment Symposium
6.13 Aug 14, 2017: ConvaTec appoints two Non-Executive Directors
6.14 Aug 14, 2017: PAVmed Reports Second Quarter 2017 Financial Results
6.15 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261%
6.16 Aug 11, 2017: SteadyMed Reports Second Quarter 2017 Financial Results and Provides Corporate Update
6.17 Aug 09, 2017: Novo Nordisk increased reported operating profit by 8% in the first six months of 2017
6.18 Aug 09, 2017: Alnylam Pharmaceuticals Reports Second Quarter 2017 Financial Results and Highlights Recent Period Activity
6.19 Aug 08, 2017: DURECT Announces Second Quarter 2017 Financial Results and Provides Corporate Update
6.20 Aug 03, 2017: ConvaTec Group: Board Changes
6.21 Aug 03, 2017: ConvaTec Group First Half 2017 Results
6.22 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results
6.23 Aug 02, 2017: Cardinal Health Reports Q4 and Fiscal 2017 Results, Provides 2018 Guidance
6.24 Aug 02, 2017: Alimera Sciences Reports Second Quarter 2017 Financial Results
6.25 Aug 01, 2017: RMS Medical Products Closes Four-Month Period Ending June 30, 2017 with Double-Digit Percentage Growth
6.26 Aug 01, 2017: Fresenius confirms its guidance after a strong second quarter with double-digit sales and earnings growth
6.27 Jul 31, 2017: SteadyMed Appoints Jeff Myers M.D. Ph.D. Vice President of Medical Affairs
6.28 Jul 28, 2017: IRADIMED Announces Second Quarter 2017 Financial Results
6.29 Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020
6.30 Jul 25, 2017: Lilly Reports Second-Quarter Results
6.31 Jul 25, 2017: 3M Delivers Second-Quarter Sales of $7.8 Billion and Earnings of $2.58 per Share; Company Updates Its 2017 Outlook
6.32 Jul 24, 2017: MicroPort Lifesciences Attends 2017 CEA Annual Meeting
6.33 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017
6.34 Jul 21, 2017: Fresenius appoints Rachel Empey as Chief Financial Officer
6.35 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results
6.36 Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board
6.37 Jul 12, 2017: Fresenius Medical Care successfully amends and extends its credit agreement, ahead of schedule
6.38 Jul 07, 2017: MPSC New COO Glendy Wang on Board
6.39 Jul 06, 2017: Fresenius Kabi expands production site in Portugal
6.40 Jul 03, 2017: Cardiome's Partner SteadyMed Submits U.S. New Drug Application for TREVYENT for the Treatment of Pulmonary Arterial Hypertension
6.41 Jul 03, 2017: Silence Therapeutics: Issue of claim in the UK High Courts
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Drug Delivery Infusion Systems - Pipeline Products by Stage of Development
Table 2: Drug Delivery Infusion Systems - Pipeline Products by Segment
Table 3: Drug Delivery Infusion Systems - Pipeline Products by Territory
Table 4: Drug Delivery Infusion Systems - Pipeline Products by Regulatory Path
Table 5: Drug Delivery Infusion Systems - Pipeline Products by Estimated Approval Date
Table 6: Drug Delivery Infusion Systems - Ongoing Clinical Trials
Table 7: Infusion Systems Companies - Pipeline Products by Stage of Development
Table 8: Drug Delivery Infusion Systems - Pipeline Products by Stage of Development
Table 9: 410 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: LifeFlow Rapid Infusion Device - Severe Hemorrhage - Product Status
Table 11: LifeFlow Rapid Infusion Device - Severe Hemorrhage - Product Description
Table 12: Acuros GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Disposable Micropump - Product Status
Table 14: Disposable Micropump - Product Description
Table 15: Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Adept IVO - Product Status
Table 17: Adept IVO - Product Description
Table 18: AktiVax Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Immunoject - Product Status
Table 20: Immunoject - Product Description
Table 21: Alnylam Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 22: ALN-HTT Infusion System - Product Status
Table 23: ALN-HTT Infusion System - Product Description
Table 24: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: BioFlo Portline Line Extension - Product Status
Table 26: BioFlo Portline Line Extension - Product Description
Table 27: Next Generation BioFlo Port - Product Status
Table 28: Next Generation BioFlo Port - Product Description
Table 29: Power Injectable Port - Product Status
Table 30: Power Injectable Port - Product Description
Table 31: Smart Port - Dual - Product Status
Table 32: Smart Port - Dual - Product Description
Table 33: Automedics Medical Systems Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 34: AutoHep System - Product Status
Table 35: AutoHep System - Product Description
Table 36: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Infusion Pump - Product Status
Table 38: Infusion Pump - Product Description
Table 39: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
Table 40: BodyGuard Quadro - Product Status
Table 41: BodyGuard Quadro - Product Description
Table 42: BioCardia Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Helix Transendocardial Delivery System - Product Status
Table 44: Helix Transendocardial Delivery System - Product Description
Table 45: BioCardia Inc - Ongoing Clinical Trials Overview
Table 46: Helix Transendocardial Delivery System - A Multicentric Controlled Phase I / IIb Study Evaluating the Safety and the Efficacy of in Vitro Expanded Peripheral Blood CD34+ Stem Cells Output by the StemXpand Automated Process, and Injected in Patients with an Acute Myocardial Infarction and a Left Ventricle Ejection Fraction (LVEF) Remaining Below or Equal to 45% after PTCA and Stent(s) Implantation Versus Standard of Care
Table 47: Helix Transendocardial Delivery System - A Phase II, Randomized, Blinded, Study of the Safety and Efficacy of Transendocardial Injection of Allogeneic Human Mesenchymal Stem Cells (hMSCs) (20 Million or 100 Million Total MSCs) in Patients with Chronic Ischemic Left Ventricular Dysfunction Secondary to Myocardial Infarction
Table 48: Helix Transendocardial Delivery System - Phase I Trial of Endocavitary Injection of Bone Marrow Derived CD133+ Cells in Ischemic Refractory Cardiomyopathy (RECARDIO Trial)
Table 49: BioQ Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Pre-Filled Infusion System - Antibiotics - Product Status
Table 51: Pre-Filled Infusion System - Antibiotics - Product Description
Table 52: Pre-Filled Infusion System - Oncology - Product Status
Table 53: Pre-Filled Infusion System - Oncology - Product Description
Table 54: Propofol Pre-Filled Infusion System - Product Status
Table 55: Propofol Pre-Filled Infusion System - Product Description
Table 56: Ropivacaine ReadyFusOR - Product Status
Table 57: Ropivacaine ReadyFusOR - Product Description
Table 58: ClearLine MD Pipeline Products & Ongoing Clinical Trials Overview
Table 59: FloStat Infusion Pump System - Product Status
Table 60: FloStat Infusion Pump System - Product Description
Table 61: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
Table 62: MIP Device - Product Status
Table 63: MIP Device - Product Description
Table 64: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Integrated Semi-Closed Loop System - Product Status
Table 66: Integrated Semi-Closed Loop System - Product Description
Table 67: Eksigent Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 68: External Drug Delivery System - Product Status
Table 69: External Drug Delivery System - Product Description
Table 70: Implantable Drug Delivery System - Product Status
Table 71: Implantable Drug Delivery System - Product Description
Table 72: Elcam Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 73: Patch Pump - Product Status
Table 74: Patch Pump - Product Description
Table 75: Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
Table 76: Drug Delivery System - Parkinson's Disease - Product Status
Table 77: Drug Delivery System - Parkinson's Disease - Product Description
Table 78: EryDel SPA Pipeline Products & Ongoing Clinical Trials Overview
Table 79: EryDex System - Product Status
Table 80: EryDex System - Product Description
Table 81: EryDel SPA - Ongoing Clinical Trials Overview
Table 82: EryDex System - Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients with Ataxia Telangiectasia
Table 83: Flowonix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 84: Implanted Drug Delivery System - Product Status
Table 85: Implanted Drug Delivery System - Product Description
Table 86: Prometra II Programmable Infusion System - Product Status
Table 87: Prometra II Programmable Infusion System - Product Description
Table 88: Flowonix Medical Inc - Ongoing Clinical Trials Overview
Table 89: Prometra II Programmable Infusion System - A Dose Ranging Pilot Study to Assess Intracerebroventricular (ICV) Delivery of Valproate in Subjects with Focal Seizures, with Temporal Lobe Onset with or without Secondary Generalization
Table 90: FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 91: FluidSync Pump - Product Status
Table 92: FluidSync Pump - Product Description
Table 93: Fluonic, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 94: SURE+ - Product Status
Table 95: SURE+ - Product Description
Table 96: Fresenius Kidney Care Pipeline Products & Ongoing Clinical Trials Overview
Table 97: Intravenous 2008MeDS - Product Status
Table 98: Intravenous 2008MeDS - Product Description
Table 99: Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 100: Smart Infusion Pump Integrated With Accelero Connect Software - Product Status
Table 101: Smart Infusion Pump Integrated With Accelero Connect Software - Product Description
Table 102: Imagnus Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 103: DeltaFlow Infusion Regulator - Product Status
Table 104: DeltaFlow Infusion Regulator - Product Description
Table 105: Innovfusion Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 106: DIVA - Product Status
Table 107: DIVA - Product Description
Table 108: EPIVA - Product Status
Table 109: EPIVA - Product Description
Table 110: INTRAVA - Product Status
Table 111: INTRAVA - Product Description
Table 112: Intarcia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 113: ITCA 650 Osmotic Pump - Product Status
Table 114: ITCA 650 Osmotic Pump - Product Description
Table 115: Intarcia Therapeutics Inc - Ongoing Clinical Trials Overview
Table 116: ITCA 650 Osmotic Pump - A Phase IIIb, Randomized, Active Comparator, Open-label, Multicenter Study to Compare the Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and to Glimepiride as Add-on Therapy to Metformin in Patients with Type 2 Diabetes
Table 117: ITCA 650 Osmotic Pump - An Open-label, Multi-center, Randomized, Phase IIIb Study to Evaluate the Safety and Tolerability of Switching to One of Two Dosing Strategies of ITCA 650 in Patients with Type 2 Diabetes Receiving Stable Doses of Liraglutide
Table 118: IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 119: Next-generation MRI IV Pump - Product Status
Table 120: Next-generation MRI IV Pump - Product Description
Table 121: Ivenix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 122: Ivenix Infusion Management System - Product Status
Table 123: Ivenix Infusion Management System - Product Description
Table 124: LifeMedix, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 125: STATfusion - Product Status
Table 126: STATfusion - Product Description
Table 127: Lynntech Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 128: Disposable Drug Infusion Pump - Product Status
Table 129: Disposable Drug Infusion Pump - Product Description
Table 130: Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 131: Compact Self-Powered Actuator - Product Status
Table 132: Compact Self-Powered Actuator - Product Description
Table 133: Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 134: Medallion Infusion System - Product Status
Table 135: Medallion Infusion System - Product Description
Table 136: Medical Device Creations Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 137: Infusion Pump - Product Status
Table 138: Infusion Pump - Product Description
Table 139: MedPrime Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 140: InfuCheck - Product Status
Table 141: InfuCheck - Product Description
Table 142: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 143: SynchroMed II+ - Product Status
Table 144: SynchroMed II+ - Product Description
Table 145: Nano Precision Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 146: Nano Portal Capsule - Product Status
Table 147: Nano Portal Capsule - Product Description
Table 148: NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 149: PeriCATH - Product Status
Table 150: PeriCATH - Product Description
Table 151: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 152: Pump For Venous Anesthesia Infusion - Product Status

List of Figures
Figure 1: Drug Delivery Infusion Systems - Pipeline Products by Stage of Development
Figure 2: Drug Delivery Infusion Systems - Pipeline Products by Segment
Figure 3: Drug Delivery Infusion Systems - Pipeline Products by Territory
Figure 4: Drug Delivery Infusion Systems - Pipeline Products by Regulatory Path
Figure 5: Drug Delivery Infusion Systems - Pipeline Products by Estimated Approval Date
Figure 6: Drug Delivery Infusion Systems - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 410 Medical Inc
  • Acuros GmbH
  • Adept Medical Ltd
  • AktiVax Inc.
  • Alnylam Pharmaceuticals Inc
  • AngioDynamics Inc
  • Automedics Medical Systems Inc
  • Baxter International Inc
  • Becton Dickinson and Co
  • BioCardia Inc
  • BioQ Pharma Inc
  • ClearLine MD
  • Debiotech SA
  • Edwards Lifesciences Corp
  • Eksigent Technologies LLC
  • Elcam Medical
  • Eli Lilly and Co
  • EryDel SPA
  • Flowonix Medical Inc
  • FluidSynchrony, LLC
  • Fluonic, Inc.
  • Fresenius Kidney Care
  • Hospira Inc
  • Imagnus Biomedical Inc.
  • Innovfusion Pte. Ltd.
  • Intarcia Therapeutics Inc
  • IRadimed Corp
  • Ivenix Inc
  • LifeMedix, LLC
  • Lynntech Inc
  • Massachusetts Institute of Technology
  • Medallion Therapeutics, Inc.
  • Medical Device Creations Ltd.
  • MedPrime Technologies Pvt. Ltd.
  • Medtronic plc
  • Nano Precision Medical Inc
  • NexGen Medical Systems Inc
  • Nipro Corp
  • Owen Mumford Ltd
  • Pavmed Inc
  • PRO-IV Medical Ltd
  • Ratio Inc
  • Rice University
  • SC Pharmaceuticals Inc
  • SteadyMed Therapeutics Inc
  • StnDrd Infusion Corporation
  • Surefire Medical Inc
  • Tandem Diabetes Care Inc
  • Terumo Corp
  • ToucheMedical Ltd.
  • Turnpoint Medical Devices Inc
  • Unilife Corporation
  • University of Minnesota
  • University of Southern California
  • vTitan Corporation Pvt Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll